Loading...
Loading...
Among the 4 tracked institutional investors we monitor, EKSO (EKSO BIONICS HLDGS INC) is held with a combined value of $831.34K across 84,751 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $338.81K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$831.34K
Total Shares Held
84,751
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $338.81K | 0.00% | +0.0% |
| 2 | VANGUARD GROUP INC | $306.30K | 0.00% | New |
| 3 | STATE STREET CORP | $147.38K | 0.00% | New |
| 4 | BlackRock, Inc. | $38.86K | 0.00% | - |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of EKSO with a position worth $338.81K, representing 0.00% of their portfolio. In total, 4 institutional investors hold EKSO with a combined value of $831.34K.
In the most recent quarter, 2 funds opened a new position in EKSO. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $831.34K worth of EKSO stock across 4 positions. The largest institutional holder is CITADEL ADVISORS LLC with $338.81K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For EKSO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their EKSO positions.